Asthma and COPD are chronic respiratory diseases that cause similar symptoms but have different causes, triggers, disease progression, and more.

Merck spends $10 billion for Verona, gaining access to its COPD medication Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in ...

If you have (COPD), your doctor may prescribe inhaled corticosteroids as part of your treatment. Learn how to take them, how they can help, what the side effects might be.

The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.

GSK just hit one of its main objectives for 2025 after getting FDA approval of anti-IL-5 antibody Nucala as a treatment for chronic obstructive pulmonary disease (COPD). Nucala (mepolizumab) has ...

Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal. The deal gives Merck access to Verona Pharma’s new ch… ...